Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

We have generated a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Using oligonucleotide microarrays, we analyzed mRNA expression levels corresponding to 12,600 transcript sequences in 186 lung tumor samples, including 139 adenocarcinomas resected from the lung. Hierarchical and probabilistic clustering of expression data defined distinct subclasses of lung adenocarcinoma. Among these were tumors with high relative expression of neuroendocrine genes and of type II pneumocyte genes, respectively. Retrospective analysis revealed a less favorable outcome for the adenocarcinomas with neuroendocrine gene expression. The diagnostic potential of expression profiling is emphasized by its ability to discriminate primary lung adenocarcinomas from metastases of extra-pulmonary origin. These results suggest that integration of expression profile data with clinical parameters could aid in diagnosis of lung cancer patients.

[1]  M. Tsutsui,et al.  Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung. , 1988, The American surgeon.

[2]  L. de Leij,et al.  Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Hirsch,et al.  Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  R. Lloyd,et al.  Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma. , 1992, Archives of pathology & laboratory medicine.

[5]  A. Gazdar,et al.  Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma , 1993, Cancer.

[6]  S. Baylin,et al.  Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Lan,et al.  IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. , 1993, Cancer research.

[8]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[9]  M. Lye,et al.  Orthostatic hypotension and vasodilatory peptides in bronchial carcinoma. , 1995, Journal of clinical pathology.

[10]  James L. Winkler,et al.  Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.

[11]  P. Brown,et al.  Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Balestrini,et al.  Cellular and functional aspects of the renal kallikrein system in health and disease. , 1998, Biological research.

[13]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R G Mark,et al.  Detection of transient ST segment episodes during ambulatory ECG monitoring. , 1998, Computers and biomedical research, an international journal.

[15]  B. Johnson,et al.  Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung , 1999, Cancer.

[16]  Joel H. Saltz,et al.  Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. , 1999, Cancer research.

[17]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[18]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[19]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Travis,et al.  Histological Classification of Lung and Pleural Tumours , 1999 .

[21]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[22]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[23]  T. Moody,et al.  TRANSFORMING GROWTH FACTOR-b1 AND ITS RECEPTORS IN HUMAN LUNG CANCER AND MOUSE LUNG CARCINOGENESIS , 2000, Experimental lung research.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[26]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Mountain,et al.  The international system for staging lung cancer. , 2000, Seminars in surgical oncology.

[28]  D. Sugarbaker,et al.  Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. , 2001, The Journal of thoracic and cardiovascular surgery.

[29]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[30]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[33]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.